Skip to main content
. 2025 May 30;13:1600706. doi: 10.3389/fbioe.2025.1600706

TABLE 3.

Changes in Secondary outcomes in both groups.

Outcomes Experimental group (n = 25) Control group (n = 23)
Baseline After 4 weeks P/t value Baseline After 4 weeks P/t value
FMA-UE 16.44 ± 11.72 25.20 ± 14.03 <0.001/5.435 16.22 ± 11.66 20.61 ± 12.10 <0.001/5.633
FMA-LE 18.80 ± 6.34 25.16 ± 472 <0.001/5.120 17.70 ± 7.36 22.91 ± 5.91 <0.001/4.816
BBS 21.84 ± 14.38 40.56 ± 11.42 <0.001/6.378 24.52 ± 18.90 30.87 ± 16.57 <0.001/5.674
BI 59.20 ± 17.18 86.20 ± 14.24 <0.001/8.332 61.96 ± 21.94 71.30 ± 17.85 <0.001/6.951